Tabassome Simon

27.5k citations
391 papers · 20.9k · 17 hit papers · h-index 71

Impact in

Papers in

Tabassome Simon

367 papers receiving 20.1k citations

Tabassome Simon's Hit Papers

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES 2025 · 19 citations
190+5+10Years since publication250500750

Peers

Tabassome Simon
Comparison fields: 5 of 153
  • Cardiology and Cardiovascular Medicine 7.1k
  • Pharmacology 1k
  • Internal Medicine 312
  • Genetics 2.2k
  • Nephrology 687
Replace Jean‐Sébastien Hulot with:
Jean‐Sébastien Hulot France
Bernd Jilma Austria
Jason D. Christie United States
Joshua A. Beckman United States
Konstantinos C. Koskinas Switzerland
P. Cacoub France
David D. Waters United States
Marcus D Flather United Kingdom
Eric L. Matteson United States
Jeffrey R. Curtis United States
Tabassome Simon relative to Jean‐Sébastien Hulot France Jean‐Sébastien Hulot's profile →
Citations per field
00.5×2×3.1×
Jean‐Sébastien Hulot · 1×
Citations per year

Countries citing papers authored by Tabassome Simon

Since Specialization
Citations

This map shows the geographic impact of Tabassome Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tabassome Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tabassome Simon more than expected).

Fields of papers citing papers by Tabassome Simon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tabassome Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tabassome Simon. The network helps show where Tabassome Simon may publish in the future.

Co-authors

The 25 scholars most cited alongside Tabassome Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tabassome Simon Line = papers co-authored together Tabassome Simon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Hit paper breakdown →
20081384
2
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
Hit paper breakdown →
2010928
3
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Hit paper breakdown →
2009894
4 2020599
5 2008586
6
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
Hit paper breakdown →
2010498
7
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
Hit paper breakdown →
2018483
8
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction
Hit paper breakdown →
2013475
9
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Hit paper breakdown →
2011413
10
Acute Myocardial Infarction
Hit paper breakdown →
2017397
11 2016351
12
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
Hit paper breakdown →
2016338
13 2014328
14
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
Hit paper breakdown →
2020311
15 2013292
16
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
Hit paper breakdown →
2019263
17
Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction
Hit paper breakdown →
2021258
18
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Hit paper breakdown →
2019244
19 2001240
20 2008237

About Tabassome Simon

Tabassome Simon is a scholar working on Cardiology and Cardiovascular Medicine, Biochemistry, Infectious Diseases, Internal Medicine and Surgery, having authored 391 papers that have together received 20.9k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (95 papers), Antiplatelet Therapy and Cardiovascular Diseases (40 papers), Lipoproteins and Cardiovascular Health (23 papers), Blood transfusion and management (18 papers), Heart Failure Treatment and Management (14 papers), COVID-19 Clinical Research Studies (14 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Inflammatory Bowel Disease (9 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.1k citations), Pharmacology (1k citations), Internal Medicine (312 citations), Genetics (2.2k citations) and Nephrology (687 citations). Tabassome Simon has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Nicolas Danchin, Jean Ferrières, Philippe Gabríel Steg, Murielle Mary‐Krause, Élodie Drouet, Étienne Puymirat, Jessica L. Mega, Céline Verstuyft, Laurent Becquemont and Nicolas F. Meneveau. Their work appears in journals such as European Heart Journal, Archives of cardiovascular diseases, Circulation, International Journal of Cardiology and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact